Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-09 Sale | 2026-04-10 4:52 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $89.84 | $738,844 | 71,776 (Direct) | View |
| 2026-03-31 Sale | 2026-04-01 5:26 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 114,367 | $83 | $9,492,596 | 90,399 (Direct) | View |
| 2026-03-31 Sale | 2026-04-01 5:26 pm | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 599 | $80.11 | $47,986 | 599 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 6:00 pm | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 27,594 | $78.05 | $2,153,712 | 1,198 (Direct) | View |
| 2026-03-12 Sale | 2026-03-13 8:30 pm | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 122,918 | $81.49 | $10,016,381 | 59,741 (Direct) | View |
| 2026-03-12 Sale | 2026-03-13 8:30 pm | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 43,682 | $81.49 | $3,559,495 | 156,318 (Direct) | View |
| 2026-03-12 Sale | 2026-03-13 8:30 pm | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 33,830 | $81.48 | $2,756,468 | 235,606 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 8:00 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $45.18 | $903,600 | 84,766 (Direct) | View |
| 2025-11-13 Sale | 2025-11-14 9:00 pm | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 196,538 | $37.55 | $7,379,887 | 389,907 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:20 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $35 | $700,000 | 104,766 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-09 Exercise | 2026-04-10 4:52 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $17.88 | 71,776 (Direct) | View |
| 2026-04-09 Exercise | 2026-04-10 4:52 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $0 | 71,776 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 40,000 | $17.88 | 90,399 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 114,367 | $0 | 90,399 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 74,367 | $8.44 | 90,399 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 599 | $0 | 599 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 599 | $8.44 | 599 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 6:00 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 27,594 | $0 | 1,198 (Direct) | View |
| 2026-03-24 Exercise | 2026-03-26 6:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 27,594 | $8.44 | 1,198 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 5:22 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 5,592 | $17.88 | 334,741 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 5:22 pm | N/A 2031-11-03 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 65,292 | $0 | 334,741 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-17 5:22 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 59,700 | $6.7 | 334,741 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A 2031-11-03 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 122,918 | $0 | 59,741 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 122,918 | $6.7 | 59,741 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 17,500 | $22.07 | 156,318 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 16,182 | $17.88 | 156,318 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 43,682 | $0 | 156,318 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 10,000 | $21.77 | 156,318 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 12,500 | $22.07 | 235,606 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 5,000 | $17.88 | 235,606 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 33,830 | $0 | 235,606 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 8,332 | $21.77 | 235,606 (Direct) | View |
| 2026-03-12 Exercise | 2026-03-13 8:30 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 7,998 | $8.44 | 235,606 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:42 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 55,000 | $0 | 55,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:41 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 100,000 | $0 | 100,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:40 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 150,000 | $0 | 150,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:40 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 150,000 | $0 | 150,000 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:39 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 355,000 | $0 | 355,000 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-05 8:00 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $0 | 84,766 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-05 8:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $8.44 | 84,766 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-14 9:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 31,250 | $22.07 | 389,907 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-14 9:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 43,816 | $17.88 | 389,907 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-14 9:00 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 196,538 | $0 | 389,907 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-14 9:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 37,494 | $21.77 | 389,907 (Direct) | View |
| 2025-11-13 Exercise | 2025-11-14 9:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat EVP, Head of R&D | 83,978 | $8.44 | 389,907 (Direct) | View |
| 2025-09-30 Option Award | 2025-10-03 7:00 pm | N/A 2035-09-30 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-09-23 Option Award | 2025-09-25 8:02 pm | N/A 2035-09-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-09-23 Option Award | 2025-09-25 8:01 pm | N/A 2035-09-23 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:20 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $0 | 104,766 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:20 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $8.44 | 104,766 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:44 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | Violin Jonathan Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:43 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | Soteropoulos Paula Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:42 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | Romano Steven J. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:41 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | McGeorge Anne Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:41 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | Lawton Alison Frances Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-22 4:40 pm | N/A 2035-05-22 | Dianthus Therapeutics Inc. | DNTH | Read Simon Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-05 5:02 pm | N/A 2035-03-04 | Dianthus Therapeutics Inc. | DNTH | KANGO SUJAY Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:27 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:23 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:21 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER | 150,000 | $0 | 150,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:18 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 150,000 | $0 | 150,000 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:13 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Garcia Marino CEO AND PRESIDENT | 340,000 | $0 | 340,000 (Direct) | View |
| 2024-09-27 Other | 2024-10-01 8:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Fairmount Funds Management LLC Kiselak Tomas Director | 62,146 | $0 | 2,762,837 (Indirect) | View |
| 2024-09-16 Option Award | 2024-09-18 5:38 pm | N/A 2034-09-15 | Dianthus Therapeutics Inc. | DNTH | Romano Steven J. Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:05 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | CARR EDWARD CHIEF ACCOUNTING OFFICER | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:05 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Veness Adam M SVP, General Counsel and Sec. | 75,000 | $0 | 75,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:04 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Randhawa Simrat CHIEF MEDICAL OFFICER | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:04 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 100,000 | $0 | 100,000 (Direct) | View |